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ABSTRACT  Polymeric IgA (plgA) is transported  by liver parenchymal cells  (hepatocytes) from 
blood  to  bile via  a receptor-mediated  process.  We  have  studied  the  intracellular  pathway 
taken by a TEPC15 mouse myeioma plgA. When from 1 pg to 1 mg 12Sl-plgA was injected into 
the saphenous vein  of a rat,  36% was transported  as intact protein  into the bile over a 3-h 
period.  The  concentration  of  transported  1251-plgA was  maximal  in  bile  30-60  min  after 
injection,  and -80% of the total 12Sl-plgA ultimately transported  had been secreted into bile 
by  90  min.  A  horseradish  peroxidase-plgA  conjugate  (~251-plgA-HRP) was transported  to  a 
similar  extent and with  kinetics  similar to that of unconjugated  1251-plgA and was therefore 
used to visualize the transport pathway. Peroxidase  cytochemistry of livers fixed in situ 2.5 to 
10  min  after  ~2Sl-plgA-HRP injection  demonstrated  a  progressive  redistribution  of  labeled 
structures from the sinusoidal area to intermediate and bile canalicular  regions  of the hepa- 
tocyte  cytoplasm.  Although  conjugate-containing  structures  began  accumulating  in the  bile 
canalicular  region at these early times,  no conjugate  was present  in bile until  20 min.  From 
7.5 to 45  min after injection  ~30% of the labeled  structures were in regions  that contained 
Golgi  complexes  and  lysosomes;  however,  we  found  no  evidence  that  either  organelle 
contained ~2Sl-plgA-HRP. At least 85% of all positive structures in the hepatocyte were vesicles 
of  110-160-nm  median  diameters,  with the  remaining  structures  accounted  for  by tubules 
and  multivesicular  bodies.  Vesicles  in  the  bile  canalicular  region  tended  to  be  larger than 
those  in  the  sinusoidal  region.  Serial  sectioning  showed  that  the  1251-plgA-HRP-containing 
structures were relatively simple (predominantly vesicular)  and that extensive interconnections 
did not exist between structures in the sinusoidal and bile canalicular regions. 
Receptor-mediated endocytosis is an important cellular proc- 
ess by which macromolecules enter cells. Liver parenchymal 
cells  (hepatocytes) internalize  a  wide  variety  of molecules 
from the circulation via this mechanism; however, once en- 
docytosed, the ligands exhibit diverse intracellular fates. Asi- 
aloglycoproteins (41)  and  epidermal growth  factor (6)  are 
taken  up  by  rat  hepatocytes  and  degraded  in  lysosomes, 
whereas polymeric leA (picA)  1 is transported from blood to 
Abbreviations used in this paper: HRP, horseradish peroxidase;  PC25- 
BSA-Sepharose 4B,  Sepharose 4B  to  which 2.9  mg  phosphoryl- 
choline25-bovine serum albumin per ml is attached; plgA, polymeric 
t2SlgA; ~25I-plgA-HRP,  conjugate between plgA and HRP; SC, secre- 
tory component; TBS, Tris-HCl-buffered saline. 
bile without degradation (24,  27,  30,  40).  The fates of the 
surface receptors can also vary in hepatocytes. The asialogly- 
coprotein receptor is reutilized for further rounds of ligand 
internalization (33,  38),  whereas the receptor for epidermal 
growth  factor  is  degraded  when  cells  are  exposed  to  the 
hormone (6a).  Secretory component (SC),  the receptor for 
plgA, is transported across the cell and secreted with its ligand 
as a complex (7,  16,  17). 
Most of the pleA that is transported from blood to bile in 
the liver is synthesized by plasma cells found in the lamina 
propria of the intestinal mucosa and enters the bloodstream 
at the thoracic duct (15).  Circulating pleA is then bound at 
the sinusoidal front of hepatocytes and transported across the 
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thesized in the  hepatocyte (7,  17,  23,  31,  34-36).  During 
transport of the SC-pIgA complex across epithelial cells, the 
membrane-anchoring domain (20-36 kD) of the transmem- 
brane receptor is  cleaved (20,  32,  34).  Morphological and 
biochemical studies have suggested  that pIgA is transported 
across the hepatocyte within small vesicles (21,  27,  37). An- 
other view has been put forward by Geuze et al., who reported 
that pIgA and asialofetuin, a ligand for the asialoglycoprotein 
receptor, are segregated from each other in a tubule network 
(compartment of uncoupling of receptors and ligand) that 
extends from the sinusoidal cell periphery to the trans-Golgi 
area  (bile  canalicular  region)  of the  hepatocyte (9).  They 
suggest that pIgA is sorted from asialoglycoproteins in this 
tubule network, with packaging of pIgA in vesicles for subse- 
quent  transport  to  the  bile  front.  Thus,  there  is  not  yet 
agreement as to the pathway by which  plgA  traverses the 
hepatocyte. 
In this study we have extended the findings of Takahashi 
et ai.  (37) and  Geuze et al.  (9).  A  horseradish  peroxidase 
(HRP)  conjugate  of mouse  mI-pIgA  (125I-pIgA-HRP) and 
electron microscopic cytochemistry  were used to identify and 
quantitate the intracellular structures involved in the uptake, 
accumulation, and  release of plgA  by rat hepatocytes. We 
have found that 85% of the total 12SI-plgA-HRP-containing 
structures at all times analyzed were discrete vesicles,  with 
tubules and multivesicular bodies composing the remaining 
15 %. In addition, we have found that the vesicles in the bile 
canalicular region of the hepatocyte tended to be larger than 
those in the sinusoidal region, which suggests that the ligand 
is repackaged during transport. Finally, serial sections showed 
that in  most cases  vesicles  and tubules were not intercon- 
nected. Preliminary portions of  this work have been presented 
elsewhere ( 11 ). 
MATERIALS  AND  METHODS 
Materials 
Phosphorylcholine chloride (calcium salt) and o-dianisidine dihydrochloride 
were from Sigma Chemical  Co.  (St. Louis,  MO); complete  and incomplete 
Freund's adjuvant were from Difco Laboratories Inc. (Detroit, MI); and female 
New Zealand white rabbits ( 10-12 lb) were supplied by Bunnyville (Littletown, 
PA). The phosphorylcholinexs-bovine serum albumin-Sepharose 4B (PC2rBSA- 
Sepharose 4B) was a generous gift of Dr. Y. C. Lee, Johns Hopkins University. 
Rabbit anti-rat SC antibody was produced using soluble SC from rat bile as an 
immunogen. Other reagents were obtained  from the same sources given in 
recent publications  from this laboratory  (l, 6,  14, 29, 41, 42) or were of the 
highest purity available commercially and were used without further purifica- 
tion. 
Preparation  of plgA 
The plasmacytoma  cell line, TEPC15,  produces  an IgA that binds phos- 
phorylcholine  (26) and was kindly supplied  by Dr. Potter  (National  Cancer 
Institute, National Institutes of  Health) and Litton Bionefics (Kensington, MD). 
The cells were grown  in  the ascites form in  pristane-primed  BALB/c  mice 
where IgA concentrations  reached 4-6 mg/ml ascites. Cells and clotted blood 
were removed from the ascites by centrifugation (1,300 g, 15 min), and sodium 
azide was added to a final concentration  of 3 mM. The ascites could be stored 
in this state at 4"C for at least 8 too. 
The entire purification  of plgA was done at 4"C. Ascites fluid (25 ml) was 
clarified by centrifugation (100,000 g, 60 rain) and then applied to a PC~-BSA- 
Sepharose 4B affinity column (2 x 5 cm) that had been equilibrated in 0.15 M 
NaCI,  20  mM Tris-HCl,  pH  7.4  (TBS). The column was washed  with  10 
column vol TBS until absorbance at 280 nm reached 0.04. 5 mM phosphoryl- 
choline chloride in TBS was used to elute IgA in a peak that was 24 ml (1.5 
column vol). Monomer and polymer  forms  oflgA were separated on a Sephadex 
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G-200 column (2.5 x  100 cm), equilibrated,  and run in TBS. The fractions 
were analyzed by native polyacrylamide gel electrophoresis (PAGE), and only 
those fractions that contained  plgA were pooled. The polymer content of the 
affinity column IgA pool ranged between 50 and 80%  and of the final plgA 
after gel filtration between 98 and  100% by densitometric  analysis of polyac- 
rylamide gels. The final preparation  was >98% IgA as judged by SDS PAGE 
(in  7.5  and 7-12%  polyacrylamide gels) using Coomassie Blue staining and 
autoradiography  of gels of t25I-plgA. Aliquots were frozen in liquid nitrogen 
and stored at -70"C. 
Preparation and Characterization of plgA-HRP 
plgA-HRP was prepared according to the procedure of Wall et al. with two 
modifications  (41). Oxidized HRP (1.33 rag) was added  to  10  mg n~l-plgA 
(4.31 x  104 cpm/zg) for the coupling reaction, and sodium cyanoborohydride 
(34 mM) was substituted for sodium borohydride in the reduction step. Uncon- 
jugated HRP was removed from conjugated and unconjugated  nSI-plgA on a 
PC2rBSA-Sepharose 4B affinity column (0.8 x 3 cm). The pooled elution peak, 
which contained  both conjugate and free 12~l-plgA, was designated ~251-plgA- 
HRP  conjugate.  The  amount  of HRP  protein  in  the  final  conjugate  was 
determined from activity measurements, by comparison with an HRP standard 
that  had  been oxidized but not coupled to plgA. The final conjugate (three 
preparations) ranged from -4 to 200 zg HRP bound per 100 mg ~2SI-plgA, or 
0.005 to 0.4 mol HRP/mol plgA (using Mr 700,000 for plgA). The 1251-plgA- 
HRP was further  characterized  by native  PAGE  and by  comparison  of its 
transport kinetics to that of unconjugated  ~25I-plgA. t251-plgA-HRP was stored 
at -70*C. 
In Vivo Clearance and Transport into Bile 
ASSESSMENT  OF 1251-plgA AND 1251-pIgA-HRP  CLEARANCE FROM 
THE  BLOOD AND TRANSPORT INTO BILE;  The in vivo clearance and 
transport of t2Sl-plgA (1-I,000  t~g) and  12SI-plgA-HRP (300-800  #g) were 
determined as previously described for other liver-specific ligands (12). The bile 
duct was cannulated with PE-10 Intramedic polyethylene tubing (Clay-Adams, 
Parsippany, NJ), and bile was collected over 10-min intervals from 0-30 min, 
15-rain intervals from 30-60 min, and 30-min intervals thereafter. 
CHARACTERIZATION  OF 1251-plgA AND 12SI-plgA-HRP  IN SERUM 
AND  BILE SAMPLES BY  AFFINITY  CHROMATOGRAPHY:  Serum  and 
bile samples containing  ml-plgA or t:51-plgA-HRP were diluted  1/10 in TBS, 
0.05% (wt/vol)  BSA and applied to a small PC2s-BSA-scpharose 4B column 
(0.8 x  3.0 cm), and 0.3-ml fractions were collected as described above (Prepa- 
ration of plgA) with 0.05% (wt/vol) BSA in all column buffers. 
Native PAGE 
plgA samples were analyzed on 5-7% polyacrylamide slab gels according to 
the method of Maizel (19) as previously described (13), but SDS was omitted 
from both resolving and slicking  gels to prevent  dissociation of light chains 
from the polymers. Samples were applied in 50 mM Tris-HC1, pH 8.9, 0.4 M 
sucrose,  0.002% (wt/vol)  bromphenol blue.  Since  separation  of the  plgA 
polymers required prolonged electrophoresls, horse spleen ferritin (300 zg) was 
used as a standard, and the gel was stopped when the fastest running band (M, 
of  apoferritin, 460,000) had migrated two-thirds the length of  the gel. Gels were 
stained with Coomassie Blue, destained (19), and dried, if ~251-pIgA was being 
analyzed, the dried gel was exposed to x-ray film (Kodak XAR-5). Bands on 
the developed film were quantilited using a GS300 Transmittance/Reflectance 
Densitometer  (Hoefer Scientific Instruments,  San Francisco, CA) interfaced 
with a Hewlett-Packard 3390A integrator (Avondale, PA). 
Characterization of 12Sl-plgA-HRP  on 
Nitrocellulose Transfers 
The 12SI-pIgA-HRP  polymers separated by native PAGE were electrophoret- 
ically transferred to nitrocellulose by the method of Towbin et at. (39). The 
nitrocellulose transfer was quenched  with 2% gelatin,  10 mM sodium phos- 
phate, pH 7.4, 0.14 M NaCI, 3 mM KCI before incubation  in 1.4 mM 3,Y- 
diaminobenzidine,  0.03% (wt/vol) H202, 50 mM Tris-HCl, pH 7.6. Bands of 
peroxidase reaction  product  appeared  in  ~30  s. After two  1-min washes in 
deionized water, the peroxidase reaction  was stopped by the addition  of 3% 
(wt/vol) trichloroacetic acid. After 15 min, the transfer was rinsed in deionized 
water, blotted dry, and exposed to x-ray film at -70°C with intensifying screen, 
and the film was developed. Morphology 
LOCALIZATION OF  t251-plgA-HRP IN SITU:  t251-plgA-HRP(0.5-1.0 
mg plgA) and mannan (I.0 rag) were mixed and injected into the sapbenous 
vein  of fasted  Sprague-Dawley  rats  under phenobarbital  anesthesia,  and at 
various times the livers were perfused in situ through the hepatic portal vein, 
first with 0.9% (wt/vol) NaC1 for 10-20 s and then with 2% glutaraldehyde in 
0.1  M sodium cacodylate, pH 7.4, for 5 rain (12). 
HRP activity in the fixed liver was detected  as described previously (41). 
After the diaminobenzidine  reaction,  sections were rinsed in Tris buffer and 
treated  with  1% OsO,,  1%  K4Fe(CN)e-3H20, 0.1  M sodium cacodylate, pH 
7.4 (filtered through a Millipore type GS filter, 0.22 ~m, Millipore Corp., New 
Bedford, MA) for 45 rain at 4"C (3). After they were rinsed in deionized water 
at  23"C for 30 s, the sections were dehydrated  and embedded  in Epon for 
electron microscopy. 
QUANTITATION  OF  1251-plgA-HRP-CONTAINING  STRUCTURES IN 
HEPATOCYTES:  The numbers and distributions  of intracellular  structures 
containing  ~251-plgA-HRP were determined  on thin sections from livers fixed 
at various times after in vivo injection of ligand. Structures were counted with 
the aid  of a  magnifying glass from random micrographs  printed  at a  final 
magnification  of 8,000.  The  hepatocyte  cytoplasm  was  divided  into  three 
regions (sinusoidal, bile canalicular, and intermediate)  and the number of ]251- 
plgA-HRP-containing  structures quantified  in each of the regions. A structure 
was considered  to be sinusoidal  when found  within  1.6  t~m of the  base of 
sinusoidal  plasma  membrane microvilli, bile canalicular  when found within 
2.2 um of the base of bile canalicular plasma membrane, and intermediate  if a 
structure did not fall into either of the other two regions. 
Golgi-lysosome regions of  hepatocytes were defined morphologically as areas 
in which Golgi stacks and lysosomes could  be identified,  and in most eases 
rough endoplasmic  reticulum  and mitochondria  were absent.  About 50%  of 
such areas were near bile canaliculi (within -2.2 ~m), and the remainder were 
in intermediate  regions as defined  above.  1251-pIgA-HRP-containing  vesicles, 
tubules, and multivesicular bodies were quantified  in the Golgi-lysosome re- 
gions of the hepatocyte.  Vesicles and tubules tended  to have a homogeneous 
intensity of internal HRP reaction product, whereas multivesicular bodies were 
larger structures  in most cases and contained  distinguishable internal  vesicles 
or other inclusions.  The diameters  of ~25I-pIgA-HRP-positive  vesicles in the 
sinusoidal, bile canalicular, and intermediate  regions were measured on micro- 
graphs of cells from livers fixed at 7.5, 15, and 30 rain  after injection  of the 
conjugate. 
ANALYSIS OF  1251-plgA-HRP-CONTAINING STRUCTURES  USING 
SERIAL SECTIONS:  The size, shape, and possible interrelationships  of con- 
jugate-containing  structures were examined  on serial 70-nm  sections of tissue 
from livers fixed 15 and 30 min after ~2~I-plgA-HRP  injection. Section thickness 
was calculated as one-half the width of section folds measured on micrographs 
of known  (and  calibrated)  magnification.  13  series  of 6-14  sections  each 
(average of 8/series) were examined. 
Other Methods 
ACID  PRECIPITATION  OF  t2sl-plgA:  Samples  of bile, plasma and 
liver bomogenate were incubated at 4"C for 30 min in 10% (wt/vol) tricbloro- 
acetic acid, 0.5% (wt/vol) phosphotungstic acid, 1 mM KI, and then sedimented 
(1,300 g,  15 min) at 4"C. The pellet was washed once with the trichloroacetic 
acid/phosphotungstic  acid solution  before the radioactivity associated with it 
was determined.  The precipitated radioactivity was a measure of t2~l covalently 
attached to plgA. 
RADIOIODINATION  OF  PROTEINS:  The plgA was radioiodinated  as 
described previously (14) to 3-5 x  l09 cpm/mg, stored in aliquots at -70"C, 
and used within 6 wk after radioiodination.  Protein A was radioiodinated  by a 
chloramine-T  procedure to a specific activity of 2-4 x  101°  cpm/mg  (29). 
RESULTS 
Biochemical Characterization of 
1251-plgA Transport 
I251-plgA  CLEARANCE  AND  TRANSPORT  TO  BILE" 
The concentration of 125I-plgA in blood reached a maximum 
between 2.5  and  10  min after intravenous injection of the 
ligand and then decreased steadily out to  180  min (Fig.  l). 
Radioactivity was first detected in bile 20  min after ligand 
injection and reached its highest concentration there between 
30  and  60  min (Fig.  1).  Routinely, by  3  h  30-40%  of the 
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FIGURE  1  The transport of intravenously injected 12Sl-plgA  into the 
bile. 12SI-plgA  (30 #g) was injected into the saphenous vein of a rat. 
At various times, the radioactivity present in bile (O) and blood (O) 
was measured  (see Materials and Methods). (A) The concentration 
of 1251-plgA  in bile and blood. (B) The cumulative transport of T251- 
plgA into bile. The inset shows the amounts of 12Sl-plgA  transported 
into  bile  after  3  h  for  three  doses  of  plgA.  This  experiment  is 
representative  of seven separate experiments. 
injected radioactivity had been transported to bile,  a  value 
that was  independent  of the  125I-plgA levels  administered, 
which ranged from 1 #g to 1 mg (inset, Fig.  1). 
In seven separate experiments, the distribution of radioac- 
tivity 180 min after injection was as follows (mean __+ SD): 36 
_  4% was transported to bile,  11  _  3% was in liver, and 34 
+  7% remained in the blood. An average of 81  _.+ 9% of the 
injected radiolabel could be accounted for in bile, blood, and 
liver, with the remaining 15-20%  in the stomach, intestine, 
thyroid, spleen, kidney, lung, colon, and heart. 180 min after 
injection  of  t25I-plgA,  <20%  of the  radioactivity  in  liver 
homogenate and >80%  of the radioactivity in stomach and 
intestine contents were acid soluble. Therefore, -12%  of the 
injected radioactivity was recovered in a degraded form (io- 
dide or small peptides) from the stomach, intestine, and liver. 
CHARACTERIZATION  OF  1251-plgA  TRANSPORTED 
TO  BILE:  The  nature of the radioactivity in  the bile was 
investigated to ascertain that 125I-plgA was being transported 
intact across the hepatocyte. More than 90%  of the radioac- 
tivity collected in bile samples up to 90 min was acid insoluble. 
Thereafter, the acid-insoluble radioactivity fell but was never 
less than 70% of the total up to 180 min. 
Native  PAGE  followed by  autoradiography was  used  to 
compare transported radioactivity with the injected 12SI-plgA 
(Fig.  2). Three  I25I-pIgA bands were present in the injected 
sample. We have designated the three I25I-bands as the dimer 
(band 3), tetramer (band 2), and hexamer (band  l) forms of 
pIgA, based on their elution behavior from the Sephadex G- 
200  column  used  to  purify  pIgA.  These  assignments  are 
consistent with data on pIgA from three other mouse plas- 
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Fig. 1 were analyzed by native PAGE (see Materials and Methods).  Bands 3, 2, and  1 represent the polymeric forms of plgA in 
our preparation which we believe to be dimer, tetramer,  and hexamer, respectively.  When this experiment was repeated, the 
distributions of radioactivity in bands 1-3 of all bile and blood samples were similar to that of the injected material. 
macytomas, where tetramer and hexamer accounted for 42- 
76%  (by weight) of the plgA (10).  Bile  samples collected at 
30,  60,  90,  and  120  min  had  radioactive  bands  that  co- 
electrophoresed with the three ~:5I-plgA bands present in the 
injected sample. No radiolabeled ligand was detected in bile 
before  15  min,  consistent  with  the  radioactivity  measure- 
ments. Although the experimental results presented in Fig. 2 
suggest that higher polymer forms of plgA were transported 
to bile faster than was the dimer, the experiment was repeated 
using a  new plgA preparation, and no apparent rate differ- 
ences were observed. Thus, it is not at present clear to what 
extent the various polymeric species produced by the mouse 
TEPC  plasmacytoma  are  differentially  transported  from 
blood to bile. However, when rat bile from uninjected animals 
was analyzed by native PAGE and immunoblotfing (14) with 
an anti-alpha chain antibody, endogenous dimer, tetramer, 
and hexamers of IgA were all present, which indicates that 
the rat system can transport these polymers, whether endog- 
enous or exogenous in origin. 
~25I-plgA collected in bile samples up to 90 min, and the 
injected  ~25I-plgA showed  the  same extent  of binding  and 
specific  hapten  elution  from  PC2rBSA-Sepharose  4B  col- 
umns, which was 70-80% of that applied. This indicated that 
the intact J25I-plgA in bile was immunologically active after 
its transport across the hepatocyte and secretion. The immu- 
noprecipitation of SC (using rabbit anti-SC) from bile samples 
collected 30-60 min after 125I-plgA  injection indicated that at 
least 40% of the transported ~25I-plgA  was bound to SC (data 
not shown). 
CHARACTERIZATION  OF  CIRCULATING  ~25I- 
pIgA:  More than  80%  of the  radioactivity in  all  plasma 
samples collected from 0-180 min was acid precipitable, and 
results of native PAGE revealed the  presence of three  ~25I- 
plgA  bands  that  co-electrophoresed  with  those  present  in 
injected '25I-plgA samples (Fig. 2). Since by these criteria the 
12~I-pIgA remaining in the circulation at 120 rain was intact, 
it was puzzling why all of the molecules initially injected were 
not cleared. Comparable amounts (70-80%) of ligand from 
both injected and 120-rain plasma samples bound to and were 
specifically eluted from PC25-BSA-Sepharose  columns, which 
indicates that antigen binding was retained in the uncleared 
pIgA.  To  examine  the  possibility that  liver transport  was 
progressively impaired during the experiment, a rat that had 
been injected 2  h  earlier with a  dose of t25I-pIgA was chal- 
lenged  with  another  dose  of  '2~I-pIgA at  I0  times greater 
specific activity. The result was unequivocal. The second 125I- 
pIgA dose was transported into bile with kinetics identical to 
that of  the first. Another possibility, that the t25I-pIgA remain- 
ing  in  the  plasma  at  120  rain  could  not  be  cleared,  was 
addressed by a study of its behavior after administration to a 
second rat. Serum prepared from the blood of a rat that had 
been injected 2 h  earlier with high specific activity 125I-pIgA 
was injected into a second rat. Calculated on the basis of the 
125I-pIgA  dose given to the first rat, only 4% more was cleared 
in  the  second  animal,  which  indicates  the  near-complete 
inability of this 125I-pIgA  to be transported into the bile.  We 
concluded that either a population of ~25I-pIgA  less active in 
transport was produced after injection into rats, or ~25I-plgA 
existed  as  a  heterogeneous population  of molecules before 
injection. 
Assessment of 1251-plgA-HRP  Conjugate 
We next determined the clearance and transport character- 
istics of the HRP conjugate of 125I-plgA. The low endogenous 
HRP  activity  in  bile  allowed  a  direct  comparison  of the 
radioactivity and peroxidase activity transported to bile in our 
initial characterization of the conjugate. The kinetics of ~2~I- 
pIgA-HRP transport into bile measured both ways was similar 
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peroxidase activity first appeared in bile at 20 rain and reached 
a maximum concentration at 60 min, within the 30-60-rain 
period in which bile ~2SI-plgA usually reached a  maximum. 
However, more of the injected peroxidase activity (56%) than 
of the injected radioactivity (38%) was transported to  bile 
(inset, Fig. 3). The t25I-pIgA-HRP radioactivity present in the 
liver (23%  of injected) after the  120-rain  experiment was 
somewhat higher than the 6-15 % range seen for the 180-min 
experiments. This probably reflects the greater percentage of 
injected t2~I-pIgA-HRP in transit through the hepatocyte at 
120 min. 
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FtGUR[  3  The transport  of  intravenously injected  ~2Sl-plgA-HRP 
conjugate into the bile. 12Sl-plgA-HRP  (300 #g pl~) was injected 
into the saphenous vein of a rat, and at various times the radioac- 
tivity (O) and peroxidase activity (0) in bile were determined. The 
inset  shows  the  distribution  of  92%  of the  radioactivity and  a 
comparison of the radioactivity and peroxidase activity in the bile 
at  120  rain.  Peroxidase  activity  of  the  conjugate could  not  be 
determined in liver and blood due to high endogenous activity. 
We next characterized the injected and transported conju- 
gates by native PAGE, the results of which are shown in Fig. 
4. The three bands observed with t25I-plgA alone were also 
present  in  the  injected preparation  of ~25I-plgA-HRP and 
contained both radiolabel and HRP activity. A comparison 
of  the relative amounts of  radioactivity  and peroxidase activity 
in each band indicated that HRP was preferentially coupled 
to higher polymeric forms. There was also radioactivity at the 
top of the separating gel that had relatively less HRP activity 
(Fig.  4, A vs.  B).  This radiolabeled material may represent 
species that have more than one plgA molecule bound per 
HRP molecule, with possible inactivation of HRP in  such 
conjugates. When the '2SI-plgA-HRP transported to bile was 
analyzed on native gels, both radioactivity and HRP activity 
were detected in the three pleA bands that corresponded to 
the major plgA's injected (Fig. 4). A discrete band containing 
HRP activity was also present above band 1, but its content 
of ~25I was not detectable above the background in that region 
of the gel (Fig. 4B). 
Finally, we found that >70%  of both peroxidase activity 
and radioactivity transported to bile between 45 and 60 min 
after  ~5I-plgA-HRP  injection  was  bound  and  specifically 
eluted from PC25-BSA-Sepharose 4B. Thus, by several criteria, 
the HRP in bile was coupled to ~2~I-plgA, which indicates that 
the conjugate had crossed the hepatocyte intact. 
Ultrastructural Examination of ~2Sl-plgA-HRP 
Transport Across  the Hepatocyte 
To characterize the transport of 1251-pIgA-HRP across the 
hepatocyte, the types and cellular distribution of structures 
that contained this electron microscopic tracer were deter- 
mined at various times after in  vivo administration  of the 
conjugate. Fig. 5 illustrates qualitatively the types of 125I-pIgA- 
HRP-containing structures present in the sinusoidal,  inter- 
mediate, and bile canalicular regions of hepatocytes 30 min 
FIGURE 4  Analysis  of the  radioactivity and  peroxidase activity of the  ~2Sl-plgA-HRP  transported  to  bile.  Bile  samples were 
separated by native PAGE and then electrophoretically transferred  to nitrocellulose. The transfer was analyzed for HRP activity 
and radioactivity as described in Materials and Methods. (A) Autoradiogram. (B) Peroxidase activity. 
HOPPE ET AL.  Hepatocyte Transport of Polymeric IgA  21 1  7 FIGURE 5  Intracellular localization of plgA-HRP in hepatocytes after its in vivo administration.  Livers were fixed by perfusion  30 
min after in vivo injection of the conjugate (0.55 rag)  and processed for HRP cytochemistry.  (a and b) Sinusoidal region.  HRP 
reaction product  is  present  in  small  vesicles  (small arrowheads)  and tubules.  SL,  sinusoidal  lumen; SF,  sinusoidal  front.  (c) 
Intermediate region.  Reaction  product is found  near  nuclei (N), and  in  vesicles similar  in  size to those  at the periphery, in 
multivesicular bodies, and also in larger vesicles (large arrowheads), but not in lysosomes (Ly) or stacks of Golgi (Go), which are 
also in this area. (d) Bile canalicular (BC) region. Conjugate is present in larger vesicles (large arrowheads) and in multivesicular 
bodies (MVB) as well as in the bile canaliculus itself. Bar, 0.5 p,m. x  24,000. 
after  injection  of the  conjugate,  when  the  distribution  of 
labeled structures was approximately equal in these regions. 
Vesicles were the predominant labeled structures seen in every 
region of the cell at all times after injection. They accounted 
for -85%  of all  J25I-pIgA-HRP-structures, with tubules and 
multivesicular bodies composing the rest. However, the sizes 
of labeled vesicles found in the  sinusoidal region (Fig.  5,  a 
and b) tended to be smaller than those near the bile canaliculus 
(Fig.  5 d). Our quantitation of these qualitative observations 
is presented below. 
CELLULAR  DISTRIBUTION  OF  1251-pIgA-HRP-CON- 
TAINING STRUCTURES:  TO obtain  an  indication  of the 
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pathway and kinetics of ligand transport, the cellular distri- 
bution of ~25I-pIgA-HRP structures was determined at various 
times after intravenous  injection  of conjugate.  The  results 
presented in Table I show a progressive redistribution of 12~I- 
pIgA-HRP structures from the sinusoidal area to intermediate 
and  bile  canalicular  regions  of the  hepatocyte  cytoplasm 
between  2.5  and  10  min  after administration  of 125I-plgA- 
HRP. The percentage of structures in the sinusoidal region 
decreased from 94 to 47 in this period, approaching a steady 
state at ~40% of total structures. The conjugate appeared in 
structures in the intermediate region before the bile canali- 
cular region, which suggests that '25I-plgA-HRP was delivered to the intermediate region immediately after the sinusoidal 
region (see 2.5 min in Table I). The percentage of structures 
in the intermediate region reached a  maximum at  10-12.5 
min  (at  34  and  36%,  respectively)  and  decreased  steadily 
thereafter. The rate at which the percentage of total structures 
in the bile canalicular region increased for the first  15  rain 
(from 0 to 30%) was faster than the increase between 15 and 
45 min (from 30 to 39%).  As illustrated qualitatively in Fig. 
5, most labeled structures were vesicles. When the diameters 
of ~25I-plgA-HRP vesicles in the three cellular regions of livers 
fixed  7.5,  15,  and  30  rain  after  conjugate  injection  were 
measured, vesicles in the bile canalicular region were found 
to be larger than those in the sinusoidal area of the hepatocyte. 
The results are presented in Fig. 6. The sizes of vesicles in the 
intermediate compartment fell between those in the other two 
regions (data not shown). 
[25I-plgA-HRP  STRUCTURES  IN  THE  GOLGI-LYSO- 
SOME  AREA:  Previous  work  from  this  laboratory estab- 
lished that epidermal growth factor (6) and asialoglycoproteins 
TABLE  I.  Distribution  of plgA-HRP-containing  Structures 
in Hepatocytes After In Vivo Injection 
Time after  Intracellular region 
administration  (% of total structures) 
(min)  Conjugate 
(total  structures  preparation  Sinusoi-  Interme-  Bile can- 
counted)  used  dal*  diate  alicular* 
2.5(65)  3  94  6  0 
5(351)  2,3,4  86  10  4 
7.5 (570)  4  57  24  19 
10(1,038)  3,4  47  34  19 
12.5(553)  4  37  36  27 
15(1,338)  2,3,4  45  25  30 
30(1,286)  3  35  29  36 
45(125)  3  40  21  39 
Livers were fixed in situ at various times after administration of 12Sl-plgA- 
HRP  (0.5-1.0  mg  plgA)  and  mannan  (1.0  rag)  and  then  processed for 
peroxidase cytochemistry  as  described  in  Materials and  Methods.  Each 
discrete structure was scored as one, regardless of size and shape. Since 
three  separate preparations of conjugate have been used in  the above 
experiments, the conjugate(s) used for each administration time is indicated. 
The standard deviation was <10% for the combined data at 5 and 10 rain 
and in the intermediate region at 15 rain. However, the combined data for 
the sinusoidal and bile canalicular regions at 15 rain had standard deviations 
of 18 and  16%,  respectively. The data for each region are presented as a 
percentage of total structures scored at a given time. 
Structures within  1.6 #m of the base of the sinusoidal plasma membrane 
microvilli. 
Structures within  2.2 #g of the  base of the  bile canalicular plasma mem- 
brane. 
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FIGURE  6  The  distribu- 
tion  of vesicle sizes in  the 
sinusoidal  and  bile  canali- 
cular  regions.  The  diame- 
ters of laSl-plgA-HRP-posi- 
tire  vesicles  in  the  sinus- 
oidal (A, C, and E) and bile 
canalicular (B, D, and F) re- 
gions  were  measured  on 
micrographs  of  cells  from 
livers fixed at 7.5 (A and B), 
15 (C and D), and 30 (E and 
F) rain after injection of the 
conjugate.  50  vesicles 
were  measured  at  each 
time point. Medians are in- 
dicated  by  the  arrow- 
heads. 
TABLE II.  Classification of plgA-HRP-containing 
Structures in Golgi-Lysosomal Regions 
Structures  Golgi-lysosome region (% of total 
in Golgi-Ly-  structures) 
sosome re- 
Time after  gion (% of  Multive- 
administra-  total struc-  sicular 
tion  tures in cell)  Tubules*  Vesicles*  bodie¢ 
min 
2.5  O  I  __  __ 
5  7  0  62  38 
7.5  19  4  83  13 
10  29  5  80  15 
12.5  35  4  75  21 
15  31  9  79  12 
30  21  8  87  5 
45  26  12  78  10 
The experiment was the same as that described in Table I.  Examples  of 
vesicles,  tubules, and multivesicular bodies are shown in the micrographs 
of Fig. 5. 
* Tubular structures -<700 nm long, 
* Circular structures -<295 nm in diameter. 
s Multivesicular bodies are vesicles >200 nm in diameter that contain distin- 
guishable vesicles or other inclusions in their lumen. 
a No structures in Golgi-lysosomal region of cell. 
(41),  two ligands destined for lysosomal degradation,  accu- 
mulated in endosomal structures within the Golgi-lysosome 
regions of hepatocytes before their entry into bona fide lyso- 
somes. Therefore, we identified and quantified the 125I-plgA- 
HRP-containing structures in such regions to determine if a 
similar accumulation was occurring before secretion of plgA 
(Table II). Ligand did enter Golgi-lysosome regions early and 
reached significant proportions there (~30%  of total struc- 
tures) before biochemical evidence of release into bile (> 15 
min). However, approximately half of these regions were very 
near bile canaliculi (~2.2 urn). More important, most labeled 
structures were neither stacks of Golgi complexes, lysosomes, 
nor endosomes typical of those in which lysosomal ligands 
accumulate. Rather, plgA-HRP was found predominantly in 
vesicles, as it was in all other regions of the cell. However, the 
combined percentage of tubules and multivesicular bodies in 
Golgi-lysosome areas was somewhat greater than that found 
over all cellular regions (~13-25 vs.  15%). Nonetheless, there 
was remarkably little change in the distribution of 125I-plgA- 
HRP among vesicles, tubules,  and multivesicular bodies in 
Golgi-lysosomal areas for times after 5 min. 
ELECTRON MICROSCOPIC SERIAL SECTION ANALYSIS 
OF  1251-plgA-HRP-CONTAINING  STRUCTURES:  Many 
sets of serial sections were examined to obtain a clearer picture 
of the  size,  shape,  and  interrelationships of the  structures 
containing  ~25I-plgA-HRP.  A  representative  series  of nine 
sections is presented in Fig. 7. Structures identified as vesicles 
on single micrographs were confirmed to be simple spherical 
structures in serial sections and between 50 and 295  nm in 
diameter. Measurements of tubules that were sectioned along 
their long axis indicated tlpat they could reach at least 700 nm 
in length.  More important, our serial section analysis indi- 
cated that the number of tubules was underestimated by only 
-5-10% 2 in the analysis of single micrographs presented in 
2 The analysis in Table II underestimated the number of tubules by 
only  5-10%.  This  estimate  was  obtained  by counting  conjugate- 
containing structures  in a  single  micrograph  from a  serial  section 
sequence and then carefully  examining the remaining micrographs 
to determine the percentage of tubules counted as vesicles. 
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 Table II (due to tubules sectioned transverse to their long axis, 
or close to transverse, appearing as vesicles as in Fig. 7, c-f). 
Multivesicular bodies (MVB in Fig. 7, a-e) were large, some- 
what spherical structures >200 nm in diameter. These struc- 
tures were occasionally seen in continuity with tubules (see 
Fig. 5), and in some cases vesicles appeared to be in continuity 
with tubules (e.g., see Fig. 7, b and c). 
DISCUSSION 
The purpose of  this study was to characterize the transcellular 
transport of plgA across the rat hepatocyte. Toward this goal, 
we biochemically characterized the transport of our ~25I-plgA 
(TEPC 15) and electron microscopic tracer (~25I-plgA-HRP). 
Once satisfied that these molecules were being transported as 
expected, we undertook electron microscopic studies to char- 
acterize the plgA transport pathway. 
Biochemical Characterization of ~2Sl-plgA and 
plgA-HRP Transport 
Unlike  asialoglycoproteins  and  asialo,agalactoglycopro- 
teins, where >80% of the injected dose is cleared by the liver 
in  l0 min (12),  ~25I-pIgA is cleared both less effectively and 
more slowly (40-55% in  180 min). The results indicate that 
mouse  ~2SI-pIgA may exist as a  mixture of transport-active 
and -inactive molecules before injection into animals. Perhaps 
SC-binding sites on some of the pIgA molecules are inacti- 
vated during the preparation of pIgA  or its radioiodination. 
Alternatively, the transport-inactive molecules may lack their 
J chain and be unable to bind to their receptor, as Brandtzaeg 
and Prydz have suggested (2). However, values in the literature 
for rat and human  ~25I-pIgA uptake by the rat agree nicely 
with  ours  and  are  from  30  to  67%  of injected  L:SI-pIgA 
transported to bile in intact rats (17, 22, 25, 30, 40), 27% in 
an isolated perfused liver (7), and 53% in cultured hepatocytes 
(18). 
When we analyzed the specific electron microscopic tracer, 
~25I-pIgA-HRP, we found that the transport kinetics of both 
radioactivity and peroxidase activity were similar (Fig.  3); 
however, relatively more peroxidase activity was transported 
to bile than was radioactivity. This difference may have been 
caused by the nature of the pIgA to which HRP was conju- 
gated. HRP was reacted with a mixture ofpIgA that contained 
one part 12~I-pIgA and  100 parts unlabeled pIgA. Therefore, 
HRP  was  coupled mainly to  unlabeled pIgA.  The greater 
transport of HRP activity could therefore be accounted for 
by better binding of  the unlabeled pIgA-HRP conjugate to SC 
than to the labeled pIgA  and labeled conjugate. Thus, the 
pIgA-HRP  conjugate  is  probably  a  better  probe  of pIgA 
transport than is the radioiodinated ligand. The substantial 
transport of both pIgA and peroxidase activity (Fig.  3), to- 
gether with our finding that m:SI-pIgA-HRP was transported 
into bile as an intact conjugate, indicated that the localization 
of HRP-containing structures accurately reflected the behav- 
ior of pIgA itself. 
Electron Microscopic Study of 
~2~I-plgA-HRP Transport 
The distribution of ~25I-plgA-HRP-containing  structures in 
the  hepatocyte during the continuous uptake of conjugate 
indicated that after internalization at the sinusoidal front, J2~I- 
plgA-HRP rapidly appeared in both the intermediate and bile 
canalicular regions of cells (Table I). ~25I-pIgA-HRP-contain- 
ing structures could be detected in the latter region as early 
as  5  min  after administration  of the  conjugate,  and  their 
percentage continued to increase up to 45 min. Within the 
intermediate and bile canalicular regions, many of  the labeled 
structures could be localized to areas in which Golgi com- 
plexes and lysosomes were also present. HRP conjugates of 
asialoorosomucoid (41 ) and epidermal growth factor (6), two 
polypeptides destined for lysosomal degradation, appear in 
Golgi-lysosome areas  of hepatocytes 4-5  min  after  their 
administration, the same time at which ~25I-pIgA-HRP  struc- 
tures appeared in these areas (Table II). However, the types 
of structures that contain these conjugates were qualitatively 
different from those that contain pIgA-HRP. Although none 
of the three ligands was present in either bona fide stacks of 
Golgi  complexes or  in  lysosomes,  asialoorosomucoid and 
epidermal growth factors were present in a more complicated 
array of tubulovesicular structures than those seen for ~25I- 
pIgA-HRP, pIgA  was found predominantly in vesicles. The 
different distributions of lysosome- vs. bile-destined ligands 
suggest either that these ligands enter the hepatocyte by inter- 
nalization into different structures or that  sorting of these 
ligands  may begin soon after endocytosis and continue to 
near completion during transit  of the  molecules to Golgi- 
lysosomal areas. Alternatively, segregation may occur rapidly 
in the Golgi-lysosomal areas, with the resulting prelysosomal 
and presecretion compartments having relatively long resi- 
dence times.  Since HRP conjugates of asialoorosomucoid, 
epidermal growth factor, and pIgA occur in similar structures 
in the sinusoidal region of the hepatocyte, we believe they 
enter cells in the same vesicles and tubules. This would require 
a sorting of ligands within the cell. The dual ligand experi- 
ments  of Courtoy et  al.  and  of Geuze et al.  support this 
hypothesis (5, 9). 
Several studies have suggested that pIgA is present only in 
vesicles during its transport across the hepatocyte (4, 2 l, 37), 
and another study has implicated smooth endoplasmic retic- 
ulum in addition to vesicles in ~25I-pIgA transport (27). We 
saw no evidence for the involvement of smooth endoplasmic 
reticulum  in  serial  sections  of  ~25I-pIgA-HRP-containing 
structures (Fig. 7). However, 85% of the total ~25I-pIgA-HRP- 
containing structures were vesicles. Nonetheless, we did find 
tubules and multivesicular bodies that contained conjugate 
(Fig.  5). Since vesicles appeared much more often than did 
tubules or multivesicular bodies in juxtaposition to the bile 
canalicular plasma membrane, vesicles are probably the struc- 
tures responsible for secretion of ~25I-pIgA into the bile. Fur- 
thermore, they were generally larger than ligand-containing 
vesicles near the sinusoidal front, implying transfer of ligand 
during  its  transport,  fusion  of vesicular carriers,  or both. 
Similar types of large  vesicles  around  bile canaliculi were 
reported by Renston et al. to contain unconjugated HRP, a 
fluid-phase pinocytic marker (28). However, this tracer, which 
was administered at very high doses (10 mg/100 g body wt), 
was  even more abundant in multivesicular bodies and sec- 
ondary lysosomes of hepatocytes, which suggests that it non- 
selectively filled all those endocytic pathways that originate at 
the sinusoidal front (i.e., lysosomal, transcellular, and perhaps 
as  yet  unidentified  routes).  Our  ~25I-pIgA-HRP conjugate 
exhibited must greater selectivity and at lower doses. 
It is not currently clear why ~25I-pIgA-HRP was found in 
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lysosomal  precursors  (6,  8,  41).  At  this  time,  we  cannot 
exclude the possibility that multivesicular bodies have a role 
in  plgA  transport. We believe a  more likely explanation is 
that  some  ~25I-plgA-HRP  molecules were directed  to  lyso- 
somes because of simple missorting, or because of an altera- 
tion of injected conjugate that still allowed its specific uptake 
into hepatocytes but not its secretion into bile. 
The  125I-plgA-HRP-containing tubules we have describe6 
may  be  analogous  to  the  compartment  of uncoupling  of 
receptors and ligand  described  by  Geuze et  at.,  who  used 
immunoelectron microscopy to detect endogenous plgA (9). 
The authors describe this compartment as an interconnected 
tubule network extending from the sinusoidal cell periphery 
to the trans-Golgi  area, with the tubules participating most 
significantly in plgA sorting occurring at the sinusoidal-lateral 
cell corners of the hepatocyte. Our data showed the presence 
of ~25I-plgA-HRP-containing tubules in both sinusoidal and 
bile  canalicular  regions of the  cell  with  no  overwhelming 
preference for one location over the other. In addition, our 
serial section analysis of ~25I-plgA-HRP-containing structures 
strongly indicated no interconnections of tubules between the 
sinusoidal and bile canalicular regions (Fig. 7). Thus, tubules 
probably do play a  role in the transport of pIgA across the 
hepatocyte, since they are found throughout the hepatocyte, 
but they appear to be concentrated in the sinusoidal and bile 
canalicular regions. However, more work is required to resolve 
the  apparent  differences  between  our  results  and  those  of 
Geuze et al.  (9),  since different morphologic methods were 
used in the two studies. 
~25I-pIgA-HRP did not appear in the bile until 20 min, even 
though  significant  numbers  of ligand-containing  structures 
had  accumulated in  the bile  canalicular region by  10  rain 
(Fig. 3 and Table I). This observation suggested that there was 
a lag between 125I-pIgA vesicle accumulation in the bile can- 
alicular region and fusion with the bile canalicular plasma 
membrane. The reason for such a lag is at present unclear but 
may involve the proteolytic cleavage of the membrane SC 
(Mr  120,000  in  reducing  SDS  PAGE)  to  free  SC,  a  step 
necessary for release of secretory IgA into the bile, since only 
free SC is detected in bile (34-36). 
In conclusion, the quantitative biochemical and morpho- 
logical approach we used to trace the pathway of pIgA across 
rat hepatocytes has significantly extended several recent mor- 
phological studies on pIgA transport (9, 37). We have shown 
that relatively simple tubules are involved in 125I-pIgA-HRP 
transport but that vesicles are the overwhelming intracellular 
structures containing pIgA. We feel that sorting of pIgA from 
lysosome-bound ligands either may begin soon after internal- 
ization and continue to completion during cellular transport, 
or  may  occur  rapidly  in  the  Golgi-lysosomal areas  of the 
hepatocyte. The larger size of vesicles in the bile canalicular 
region of the hepatocyte relative to those in the sinusoidal 
region  suggests  that  conjugate  undergoes  some  change  in 
"packaging"  during its transport across the hepatocyte.  Fi- 
nally, our serial section analysis indicates that there are no 
extensive interconnections between structures in the sinusoi- 
dal and bile canalicular regions, leading us to conclude that 
pIgA  is  transported  from  blood  to  bile  within  membrane 
bound  compartments,  which  themselves  move  across  the 
hepatocyte, and not through a tubular complex, which con- 
nects sinusoidal and bile canalicular regions. 
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